Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
This walkthrough guides you through stock index calculation with a concrete example, detailing data inputs, weighting decisions, and the final result.
17,212 articlesA large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Geopolitics and energy markets collide when Iran tensions rise. This guide digs into how oil stocks historically resp...
Insider moves can reveal much about a company’s outlook, but they aren’t a single data point. This article breaks dow...
Palantir has wowed investors with AI-enabled results, but its sky-high valuation raises questions. This guide uses hi...
A major fund’s exit from Ocular Therapeutix raises questions about timing, liquidity, and sector signals. This articl...
Walmart recently dropped out of the trillion-dollar club, leaving investors to wonder if the stock still deserves a p...
Insider activity can be a clue about a company’s path, but the motives are varied. This article dissects iradimed's s...
A harsh week for AI chips created real bargains. This article identifies three beaten-down chip stocks worth a closer...
JetBlue sparked attention by boosting its Q2 unit-revenue outlook, lifting airline sentiment and offering clues for t...
When a Tanger director cashed $518,000, investors take notice. This article breaks down insider trades, what signals ...
When a chief operating officer sells stock, investors take notice. This article breaks down the implications, explain...